Letters to HCPs

Important information for Healthcare Professionals

Direct Healthcare Professional Communication on approved dosing regimens for Accord Bivalirudin for Percutaneous Coronary Intervention (PCI), following reports of inappropriate use

This letter will provide guidance on the dosing regimen, administration instructions, safety concerns and suspected adverse reactions to HCPs for patients undergoing Percutaneous Coronary Intervention (PCI).

For Healthcare Professionals